^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    ColonAiQ Multi-Gene Methylation Detection Test

    Company:
    Singlera Genomics
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    A cutting-edge, multi-locus blood-based assay specifically targeting circulating tumor DNA methylation. This groundbreaking technology has demonstrated unparalleled success in non-invasive early detection for both colorectal cancer (CRC) and advanced adenoma (AA). ColonAiQ® is poised to redefine the landscape of CRC screening, providing a powerful tool for identifying these conditions at their earliest stages.
    Cancer:
    Colorectal Cancer
    Method:
    ctDNA Methylation